Salvage surgery for primary non-Hodgkin's lymphoma of the thyroid gland with histopathological complete response to radio-chemotherapy: Report of a case

被引:0
作者
Shimizu, J
Ishida, Y
Takehara, A
Kinoshita, T
Tatsuzawa, Y
Kawaura, Y
Matsumoto, I
Imai, M
机构
[1] Saiseikai Kanazawa Hosp, Dept Surg, Kanazawa, Ishikawa 9200353, Japan
[2] Komatsu Municipal Hosp, Dept Surg, Komatsu 9238560, Japan
[3] Ishikawa Prefectural Nursing Univ, Dept Pathol, Takamatsu, Kagawa 9291212, Japan
关键词
thyroid; non-Hodgkin's lymphoma; radiotherapy; chemotherapy;
D O I
10.1007/s005950300007
中图分类号
R61 [外科手术学];
学科分类号
摘要
A 74-year-old woman was admitted to a local hospital for investigation of a rapidly growing mass in her neck, and exertional dyspnea. An open biopsy confirmed a diagnosis of non-Hodgkin's lymphoma of the thyroid (NHLT), of a diffuse large cell type. The patient was referred to our department for radio-chemotherapy for stage I E NHLT. She was given radiotherapy in the form of 40Gy radiation directed at her neck and superior mediastinum, with one course of chemotherapy using cyclophosphamide, adriamycin, vincristine, and prednisolone (CHOP). After radio-chemotherapy, the tumor was obviously smaller. Because the patient refused further chemotherapy, she underwent salvage surgery, after being sufficiently advised, and with her informed consent. Histological examination of the removed thyroid tissue showed that the radio-chemotherapy had produced a complete response. Thus, we believe that an open biopsy should be performed early to confirm the diagnosis of lymphoma histologically and to determine the degree of malignancy. We also stress the fact that NHLT is presently most effectively treated by radiotherapy combined with several courses of CHOP chemotherapy. The role of surgery in the treatment of NHLT is diminishing.
引用
收藏
页码:45 / 48
页数:4
相关论文
共 17 条
  • [1] AOZASA K, 1986, CANCER-AM CANCER SOC, V58, P100, DOI 10.1002/1097-0142(19860701)58:1<100::AID-CNCR2820580118>3.0.CO
  • [2] 2-1
  • [3] AOZASA K, 1990, ACTA PATHOL JAPON, V40, P459
  • [4] BURKE JS, 1977, CANCER-AM CANCER SOC, V39, P1587, DOI 10.1002/1097-0142(197704)39:4<1587::AID-CNCR2820390434>3.0.CO
  • [5] 2-V
  • [6] COMPAGNO J, 1980, AM J CLIN PATHOL, V74, P1
  • [7] THYMIDINE KINASE - A TUMOR-MARKER WITH PROGNOSTIC VALUE FOR NON-HODGKINS-LYMPHOMA AND A BROAD RANGE OF POTENTIAL CLINICAL-APPLICATIONS
    HALLEK, M
    WANDERS, L
    STROHMEYER, S
    EMMERICH, B
    [J]. ANNALS OF HEMATOLOGY, 1992, 65 (01) : 1 - 5
  • [8] KATO I, 1985, JPN J CANCER RES, V76, P1085
  • [9] CLINICAL ASPECTS OF PRIMARY THYROID LYMPHOMA - DIAGNOSIS AND TREATMENT BASED ON OUR EXPERIENCE OF 119 CASES
    MATSUZUKA, F
    MIYAUCHI, A
    KATAYAMA, S
    NARABAYASHI, I
    IKEDA, H
    KUMA, K
    SUGAWARA, M
    [J]. THYROID, 1993, 3 (02) : 93 - 99
  • [10] Micke O, 1997, ANTICANCER RES, V17, P3007